Detalhe da pesquisa
1.
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Breast Cancer Res Treat
; 170(1): 189-196, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470806
2.
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.
J Hum Genet
; 61(6): 515-22, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911350
3.
P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib.
Invest New Drugs
; 33(5): 1012-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26123925
4.
Buparlisib is a brain penetrable pan-PI3K inhibitor.
Sci Rep
; 8(1): 10784, 2018 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018387
5.
PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models.
Clin Cancer Res
; 23(5): 1286-1298, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553832